Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma
Open Access
- 2 August 2021
- journal article
- research article
- Published by Taylor & Francis in Hepatic Oncology
- Vol. 8 (4) , HEP39
Abstract
While researchers know that tumor mutational burden (TMB) is low in hepatocellular carcinoma (HCC), prior studies have not investigated TMB in cirrhosis, small early HCC and progressed HCC. HCC (n ...Keywords
This publication has 37 references indexed in Scilit:
- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survivalGenome Research, 2014
- Signatures of mutational processes in human cancerNature, 2013
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaJournal of Hepatology, 2009
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009
- East–West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma #Hepatology, 2009
- Cholestasis is a marker for hepatocellular carcinomas displaying β‐catenin mutationsThe Journal of Pathology, 2007
- Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosisHepatology, 2007
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006
- Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosisCancer, 2005